Investing Profile

Martin Heidecker

InvestorVC
Chief Investment Officer at AMR Actions Fund
amractionfund.comCambridge, Massachusetts
Photo of Martin Heidecker, Investor at AMR Action Fund
cb
$100K - $5.0M
$1.5M
9
$1B
CompanyStageDateRound SizeTotal Raised
Vedanta Biosciences
Series EApr 2023$110M
$110M
Co-investors: Curt LaBelle (Adjuvant Capital)
BioVersys
Series CJan 2023$9M
$9M
Venatorx Pharmaceuticals
Series CApr 2022$34M
$76M
Co-investors: Brett Zbar (General Atlantic), Carlo Rizzuto (Versant Ventures)
Adaptive Phage Therapeutics
Series BApr 2022$20M
$61M
Co-investors: Jonathan Leff (Deerfield Management)
Libra Therapeutics
Series ASep 2020$29M
$29M
Rgenta Therapeutics
SeedApr 2020$20M
$90M
Co-investors: Fei Shen (Boehringer Ingelheim Venture Fund), Hongbo Lu (Vivo Capital)
Sentien Biotechnologies
Series AApr 2017$12M
$12M
Co-investors: Johannes Fruehauf (Mission BioCapital)
Sentieon
Series AApr 2014$4M
$4M
Co-investors: Johannes Fruehauf (Mission BioCapital)